Best Stock Screeners

Finviz is widely regarded as the best free stock screener available. Its screener page lets you filter stocks across dozens of fundamental, technical, and descriptive criteria with instant visual results, and the completely free tier covers most screening needs without requiring an account. The heatmap view gives you an at-a-glance picture of the entire market, and the preset filters make it easy to run common screens like oversold stocks or high-dividend payers without building criteria from scratch. The Elite plan, from $39.50/month, adds real-time data, backtesting, and advanced charting for investors who outgrow the free tier's capabilities. The tradeoffs are mostly cosmetic: free-tier quotes are delayed by 20 minutes rather than real-time, which matters more for active traders than long-term screeners, and the charts and overall interface feel noticeably dated compared to newer, more visually modern platforms.

TradingView combines the best charting platform in the industry with a powerful built-in stock screener. You can screen for stocks and immediately pull up world-class charts without leaving the platform, and the screener supports custom filters, technical indicators, and even Pine Script-based screening criteria for investors who want to code their own logic. The active social community adds another layer where traders share screens and strategies, and coverage extends across stocks, forex, crypto, and futures globally rather than being US-stock-only. A free tier gets you started, with Pro pricing from $14.95/month unlocking more indicators and alerts. The tradeoff is focus: the free plan limits the number of indicators and alerts you can run simultaneously, and the screener itself can feel secondary to TradingView's core charting strength, so screening-first users may find dedicated fundamental screeners like Stock Analysis or Finviz a better primary tool.

Stock Analysis has quickly become one of the best free fundamental screeners on the web. It offers clean, fast access to financial statements, valuation metrics, and screening filters without the clutter of legacy platforms, covering hundreds of data points including revenue growth, margins, valuation ratios, and analyst estimates. The free tier is remarkably generous for individual investors, and the platform sees regular updates adding new features and data points over time. Premium runs just $9.99/month for extended data and screening depth, among the most affordable upgrades on this list. The tradeoffs reflect its fundamentals-first design: technical screening filters are noticeably limited compared to a chart-and-indicator-focused tool like Finviz or TradingView, and as a relatively newer platform it has a smaller community and shorter track record than more established, decades-old screeners.

Yahoo Finance remains one of the most accessible stock screeners for beginners. The interface is straightforward, the data is reliable, and it integrates seamlessly with Yahoo Finance's broader ecosystem of news, portfolios, and watchlists, so screening results connect directly to tools you're probably already using. While it lacks the depth of dedicated screeners, its simplicity and brand recognition make it a natural starting point for new investors learning to filter stocks for the first time. The core screener is free, with Yahoo Finance Plus available from $49.99/year adding more advanced charting and insights on top. The tradeoffs are what you'd expect from a beginner-friendly, general-purpose tool: screening criteria are fairly basic compared to dedicated platforms like Finviz or Koyfin, and the free tier's ad-heavy experience can be a real distraction during extended research sessions.

TIKR Terminal brings institutional-quality financial data to individual investors at a fraction of the cost of a Bloomberg terminal. The screener lets you filter stocks using detailed financial metrics, and the platform provides 10+ years of financial history, analyst estimates, and global coverage across 90+ exchanges — a genuinely wide net most competitors don't cast. It's particularly popular with value investors who want deep fundamental data for screening rather than a quick technical scan, delivered through a clean, terminal-style interface built for serious analysis. A free tier is available, with Plus pricing from $19.95/month unlocking the full historical dataset and screener access. The tradeoffs: the free tier's screener access is genuinely limited compared to the paid plan, and TIKR has no technical analysis or charting tools built in at all, so pairing it with a charting platform like TradingView fills that gap.

Koyfin is a data-rich financial platform that offers one of the most customizable screeners available. You can build screens using hundreds of financial metrics, create custom formulas, and save screening templates for repeated use, rather than rebuilding your criteria from scratch every session. The platform also provides excellent dashboards, financial modeling tools, and market analytics that complement the screener directly, making it a genuine research hub rather than a screener bolted onto something else. A free tier is available, with Plus pricing from $25/month for the most advanced formula-building and template-saving features. The tradeoffs mirror that depth: the sheer number of customizable options creates a steep learning curve for new users, and the free tier limits the number of saved screens and data exports you can keep active at once, pushing serious users toward the paid plan sooner than some competitors.

Fidelity's stock screener is one of the best brokerage-integrated screening tools available. It offers robust filtering across fundamentals, technicals, ESG criteria, and analyst ratings, all connected directly to your Fidelity brokerage account, with ESG screening criteria that most standalone screeners on this list simply don't offer. The ability to screen, research, and trade without leaving the platform makes it seamless for existing Fidelity customers, and it includes access to third-party research from providers like Refinitiv at no extra charge. There's no additional cost beyond having a Fidelity account, making it effectively free for anyone already banking there. The tradeoffs are access-related: you need a Fidelity account to use it at all, ruling it out if you brokerage elsewhere, and the interface feels noticeably more corporate and less modern than purpose-built standalone screening tools like Finviz or Koyfin.

Charles Schwab's stock screener provides solid screening capabilities integrated with the Schwab trading platform. Following the Schwab-TD Ameritrade merger, the platform has consolidated the best features of both brokerages into one experience, covering fundamentals, technicals, and Schwab's proprietary ratings alongside traditional screening criteria. It pairs well with Schwab's extensive research library and educational resources, which is genuinely useful for investors still learning how to build effective screens rather than already knowing exactly what they want. Access is free with a Schwab account, with no additional screener-specific subscription required on top. The tradeoffs mirror Fidelity's brokerage-locked model: you need a Schwab account to access the full screener rather than being able to use it standalone, and its screening depth is more limited than dedicated screener platforms like Finviz, Koyfin, or TIKR Terminal built specifically around this one function.

GuruFocus offers a screener specifically designed for value investors. It includes unique screening criteria like the Piotroski F-Score, Altman Z-Score, Graham Number, and GuruFocus's own predictability rank — metrics most general-purpose screeners simply don't calculate at all. You can also screen for stocks that specific gurus are buying or holding, and the platform's All-in-One Screener combines over 500 data points with guru portfolio tracking and 30+ years of financial data for genuinely long-term screening. Limited free access is available, with the full screener requiring a $449/year subscription — among the steepest prices in this category. The tradeoffs reflect that premium positioning: the price itself is a real barrier for casual users compared to $10-25/month competitors, and the sheer density of data points packed into every screen can overwhelm users who just want a quick filter rather than an exhaustive value-investing research tool.

WallStreetZen takes a simplified approach to stock screening by providing quick stock health checks and easy-to-understand scores. Instead of overwhelming users with hundreds of metrics, it distills analysis into pass/fail checks across valuation, financial health, growth, and dividends, giving you a fast read without digging through raw financial statements yourself. The screener is designed for investors who want fast answers rather than deep customization, making it ideal for quick idea validation before committing to deeper research elsewhere. A free tier covers the basics, with Premium starting at $19.99/month for the full pass/fail breakdown across all metrics. The tradeoffs are exactly what you'd expect from that simplicity-first design: screening criteria are genuinely limited for advanced users who want granular control, and the platform lacks technical analysis and charting capabilities entirely, so it works best as a first-pass filter rather than a complete screening solution.

Seeking Alpha's stock screener integrates with its proprietary Quant Ratings system, which algorithmically scores stocks based on valuation, growth, profitability, momentum, and EPS revisions. The screener lets you filter by these quant scores alongside traditional fundamental metrics, and its dividend screening tools in particular are among the best available on any platform in this category. Combined with Seeking Alpha's extensive library of community-written stock analysis, it provides both quantitative screening and qualitative research in one platform rather than requiring a separate tool for each. A free tier samples the screener, with Premium at $239/year required for full Quant Rating access across every stock. The tradeoffs mirror Seeking Alpha's broader platform: a full Premium subscription is required to unlock the complete quant scoring system, and since the underlying community articles vary significantly in quality, the qualitative side of the platform needs more filtering than the quantitative screener itself.

Investing.com offers one of the broadest international stock screeners available. While most screeners focus primarily on US markets, Investing.com covers stocks from exchanges around the world, making it ideal for investors seeking global diversification rather than a US-only tool. The screener includes fundamental and technical filters, and the platform provides real-time data, news, and analysis across multiple asset classes and countries — with real-time data included even in the free tier, unlike several US-focused competitors that delay quotes. It's also available in multiple languages, a genuine advantage for the platform's global user base. The tradeoffs: the free version carries a noticeably ad-heavy experience that can slow down research sessions, and the overall screener interface feels less polished than more purpose-built, US-focused competitors like Finviz or Koyfin, so international coverage comes at the cost of some interface refinement.